LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹2.12 Cr | ₹4.29 Cr | ₹3.83 Cr | ₹4.01 Cr | ₹4.23 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of LYKA LABS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹2.12 Cr |
| Mar2025 | ₹4.29 Cr |
| Mar2024 | ₹3.83 Cr |
| Mar2023 | ₹4.01 Cr |
| Mar2022 | ₹4.23 Cr |
How is Deferred Tax Assets / Liabilities of LYKA LABS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹2.12 Cr | -50.59 | |
| Mar2025 | ₹4.29 Cr | 12.15 | |
| Mar2024 | ₹3.83 Cr | -4.54 | |
| Mar2023 | ₹4.01 Cr | -5.27 | |
| Mar2022 | ₹4.23 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹283.7 Cr | -6.9% | 3.1% | -14.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,562.0 Cr | -3.2% | -7.8% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,572.0 Cr | -3.3% | -0.2% | 63.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,871.0 Cr | -2.4% | -5% | 33.6% | Stock Analytics | |
| CIPLA | ₹107,770.0 Cr | -4% | -5.6% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,829.0 Cr | -1.2% | 4.1% | -4.2% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -6.9% |
3.1% |
-14.1% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses